CN112569315A - 一种抗癌固本适宜癌症防治的药膳粉 - Google Patents
一种抗癌固本适宜癌症防治的药膳粉 Download PDFInfo
- Publication number
- CN112569315A CN112569315A CN202011643413.3A CN202011643413A CN112569315A CN 112569315 A CN112569315 A CN 112569315A CN 202011643413 A CN202011643413 A CN 202011643413A CN 112569315 A CN112569315 A CN 112569315A
- Authority
- CN
- China
- Prior art keywords
- preventing
- medicinal powder
- cancer
- treating
- resisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 66
- 239000000843 powder Substances 0.000 title claims abstract description 38
- 201000011510 cancer Diseases 0.000 title claims description 40
- 235000005911 diet Nutrition 0.000 title claims description 10
- 230000037213 diet Effects 0.000 title claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 12
- 239000012535 impurity Substances 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 238000001694 spray drying Methods 0.000 claims abstract description 12
- 238000005303 weighing Methods 0.000 claims abstract description 12
- 235000010518 Canavalia gladiata Nutrition 0.000 claims abstract description 10
- 241000234435 Lilium Species 0.000 claims abstract description 10
- 240000004371 Panax ginseng Species 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 10
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 9
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 9
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 9
- 241000271042 Gloydius halys Species 0.000 claims abstract description 9
- 240000000249 Morus alba Species 0.000 claims abstract description 9
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 9
- 241000270273 Ptyas dhumnades Species 0.000 claims abstract description 9
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 8
- 244000189799 Asimina triloba Species 0.000 claims abstract description 8
- 244000045232 Canavalia ensiformis Species 0.000 claims abstract description 8
- 235000010520 Canavalia ensiformis Nutrition 0.000 claims abstract description 8
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 8
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 8
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 8
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 7
- 240000008672 Gynura procumbens Species 0.000 claims abstract description 7
- 235000018457 Gynura procumbens Nutrition 0.000 claims abstract description 7
- 240000002624 Mespilus germanica Species 0.000 claims abstract description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 6
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 6
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 3
- 244000248825 Peltandra virginica Species 0.000 claims abstract 2
- 244000269722 Thea sinensis Species 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims description 54
- 230000001093 anti-cancer Effects 0.000 claims description 8
- 240000000038 Ziziphus mauritiana Species 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 18
- 208000026435 phlegm Diseases 0.000 abstract description 18
- 230000006870 function Effects 0.000 abstract description 14
- 238000005728 strengthening Methods 0.000 abstract description 12
- 238000002512 chemotherapy Methods 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 5
- 230000003902 lesion Effects 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 4
- 230000008506 pathogenesis Effects 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000006072 paste Substances 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 description 28
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 230000001737 promoting effect Effects 0.000 description 18
- 241000270295 Serpentes Species 0.000 description 12
- 241001122767 Theaceae Species 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 244000197580 Poria cocos Species 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 241000245665 Taraxacum Species 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 108010047620 Phytohemagglutinins Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000001885 phytohemagglutinin Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 240000003049 Canavalia gladiata Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 229940044683 chemotherapy drug Drugs 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 241001597062 Channa argus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241001530884 Gynura segetum Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 240000009120 Phyllanthus emblica Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010062662 Uterine mass Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 238000003811 acetone extraction Methods 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 230000005880 cancer cell killing Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000021603 oncosis Effects 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 239000009685 tusanqi Substances 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
将上述原料中的薏苡仁挑拣去杂、剔除霉变,按重量份数称取,以50%的乙醇提取,将提取液经喷雾干燥制得干燥药粉;将刀豆、茯苓、蝮蛇、乌梢蛇、昆布、蒲公英、桃仁、木瓜、人参、桑椹、枸杞子、蛹虫草、平卧菊三七、百合、茶树花、余甘子、大枣挑拣去杂、剔除霉变,按重量份数称取,加入70~80℃的热水内浸泡六小时,煎煮三次,每次煎煮二小时,将三次煎煮液混合,经喷雾干燥制得干燥药粉,与如上薏苡仁提取药粉合并混匀,即成为生产制做一种抗癌固本适宜癌症防治的药膳粉,既可以直接冲饮,也可以制作成颗粒剂、浓缩口服液、丸剂、片剂、膏剂、胶囊剂,具有针对癌症病机,以扶正固本、化痰祛瘀、解毒散结相结合、防治并举的系列作用,也是配合癌症放化疗和手术康复使用的中医药膳佳品,是一种安全有效、性平气和、长期依从性高、普遍适宜各种癌症和癌前病变及其高危人群防治与康复的中药配方制品。
Description
技术领域:本发明涉及一种抗癌固本适宜癌症防治的药膳粉。
背景技术:恶性肿瘤主要包括癌与肉瘤,癌症是恶性肿瘤的总称,是一类严重损害劳动力,威胁人类生命健康的常见病;据有关资料,我国新发现的肿瘤病人约百万以上,带瘤生存的有数百万之众,给家庭社会带来了巨大影响,癌症的防治成为当今世界医学领域的重要研究课题和迫切任务。
中医同癌症的斗争有数千年的历史,早在《黄帝内经》就对肿瘤作了较全面的阐述,所载的肠覃、石瘕、噎膈、反胃等病症与现代某些恶性肿瘤的临床表现极为相似,认为癌症的病机是正虚邪实;正虚是脏腑气血不足,邪实是痰血瘀阻和邪毒内结,从而奠定了中医防治癌症的理论基础,依据该理论和长期的医疗实践,以扶正固本、化痰祛瘀、解毒散结为法,采用药食同源的中药材原料,获得安全有效,适宜长期食用,且具有较高依从性的预防与康复癌症并举之技术成果,则是该专利中药组方的显著特色和优势。
本发明配方依据中医有关理论作为指导,采用祖国医学数千年传承的肿瘤防治技术,参照现代中药药理研究与西方医学实验室研究成果,针对中医学癌症病理机制,以辨证施治为立法原则,采用药食同源作为中药组方原料,依照中医君臣佐使配方理论与现代中药药理研究成果相结合的思路设计而成。
目前现有技术中,尚未有全面针对癌症病机,以扶正固本、化痰祛瘀、解毒散结相结合防治并举的、适于癌症高危人群、癌前病变、和临床癌症患者、也是配合癌症放化疗和手术康复使用的中药类配方和相关技术成果。
发明内容:本发明目的是提供一种安全有效、性平气和、长期依从性高、普遍适宜各种癌症和癌前病变及其高危人群防治与康复、配合癌症放化疗和手术康复使用的中医药膳类型的配方。
本发明是由下述方案实现的。
中药的配方及制备方法:
制备方法:
将上述原料中的薏苡仁挑拣去杂、剔除霉变,按重量份数称取,以50%的乙醇提取,将提取液经喷雾干燥制得干燥药粉;将刀豆、茯苓、蝮蛇、乌梢蛇、昆布、蒲公英、桃仁、木瓜、人参、桑椹、枸杞子、蛹虫草、平卧菊三七、百合、茶树花、余甘子、大枣挑拣去杂、剔除霉变,按重量份数称取,加入70~80℃的热水内浸泡六小时,煎煮三次,每次煎煮二小时,将三次煎煮液混合,经喷雾干燥制得干燥药粉,与如上薏苡仁提取药粉合并混匀,即成为一种抗癌固本适宜癌症防治的药膳粉。
中药组方意义是:
根据中医理论,癌症病机是正虚邪实;正虚是脏腑气血不足,邪实是痰血瘀阻和邪毒内结;故本方祛邪以薏苡仁、茯苓、蝮蛇、乌梢蛇、刀豆、蒲公英、桃仁、昆布、茶树花、余甘子能化瘀、祛痰、行气、解毒、散结以抗癌、抑癌;补虚以人参、蛹虫草、枸杞、桑椹、百合、大枣补气养血滋阴、调补肝肾以固本强化正气,防治癌症耗伤正气和放化疗手术对机体的损伤,该组方具有扶正祛邪攻补兼施之功,凉温配伍药效具有平和之性,因而适宜相应人群之所有体质人士使用;又因该方药均为药食同源类中药,具有安全性,所以能够长期食用,且防治皆宜。
中药的功效是:
薏苡仁:味甘淡,性凉;健脾渗湿、除痹止泻、清热排脓;脾为生痰之源,该药能健脾化湿,以绝痰生之源,又能清热解毒,针对癌症形成的病理产物痰和瘀毒具有较好的清除作用,作为本方的主药之一;现代药理研究显示薏苡仁具有显著的抗肿瘤作用,醇提取、丙酮提取和粉粹食用均具有肯定的抗瘤功效,50%醇提取物对体外培养的扁平上皮癌细胞有促进角化的作用(王本祥《现代中药药理研究》542页,薏苡仁);薏苡仁现代应用,单用或复方应用皆可用于多种肿瘤,收效尚佳(李家庚等《实用中医肿瘤病学》第二版,898页,薏苡仁)。
刀豆:味甘,性温;温中,下气,止呃;主治虚寒呃逆,呕吐;现代药理研究显示刀豆含有植物血球凝集素,具有抗肿瘤作用,该凝集素可引起人淋巴细胞的变形,但并不产生相应的细胞毒性,还可以抑制其他植物血球凝集素引起的细胞毒性;刀豆植物血球凝集素还能使肿瘤细胞重新恢复到正常细胞的生长状态等(王本祥《现代中药药理研究》658页,刀豆)。
茯苓:味甘、淡,性平;健脾补中,养心安神,利水渗湿;主治水湿停滞,小便不利,水肿胀满,食少便溏,心悸失眠等,针对癌症形成的病理产物“痰”具有较好的作用,为本方主药;现代药理研究显示具有抑制肿瘤、提高免疫、催眠、促进造血作用,能增强生理活性,刺激人体免疫系统的功能恢复,诱生和促生干扰素和白细胞调节素,间接抗病毒、抗肿瘤,减轻放射与化疗的副作用,尚有延缓衰老、安神健胃、美容养颜的作用(王本祥《现代中药药理研究》529页,茯苓)。
蝮蛇:味甘,性温;祛风攻毒,用于治疗中风、痹证、消渴病和麻风病等,也为本方主药;现代药理研究显示蝮蛇具有显著广谱的抗癌作用,对多种癌瘤有效,同时有抗炎、抗凝血、降血脂、扩血管和降压、抗溃疡作用(王本祥《现代中药药理研究》502页,蝮蛇)。
乌梢蛇:性味甘、平;功能祛风、通络、止痉;用于风湿顽痹,麻木,拘挛,中风口眼歪斜,半身不遂,抽搐痉挛,破伤风,麻风,疥癣(《中华人民共和国药典一部》72页,乌梢蛇);使用本品意在通经络以散结痹,促进肿瘤消除;现在研究显示,蛇类药材中含有大量的蛋白质和脂肪类成分,目前普遍认为,氨基酸对人体的健康有着极其重要的生理意义,药物中的氨基酸对临床治疗疾病能够产生较大的影响;蛇肉、蛇鞭、蛇头、蛇皮、蛇蛋、蛇胆均含有人体所必学的8种氨基酸,其中以蛇肉中氨基酸含量最高,此外蛇蛋和蛇皮中含有大量的粗蛋白,这对皮肤疾病的治疗具有重要意义;乌梢蛇中还含有核苷类成分,如腺苷、尿苷等核苷成分,其不仅是构成核酸RNA、DNA单体的前体,也是生物氧化、能量代谢中的能源物质和抗病毒、抗肿瘤药物的中间体,具有重要的生物活性;此外,乌梢蛇中还不同程度的含有、Mn、Fe、Ca、Mg等微量元素,即可作为人体营养成分加以补充,又具有重要的生物活性,对于皮肤保健和抗皮肤老化、消退老年斑有较好的作用。
昆布:味咸,性寒;软坚散结,消痰行水;主治瘿瘤,瘰疬,痰饮,咳嗽,睾丸肿痛等,针对癌症之痰血瘀阻邪实机制,为消除肿瘤实体之良药;现代中药药理研究显示有抗肿瘤,防癌、抗癌,抗辐射,降压,强心,抗凝,抗动脉硬化等(王本祥《现代中药药理研究》974页,昆布)。
蒲公英:味苦、甘,性寒;功能清热利湿,解毒疗疮;治痈肿疮疡,湿热黄疸,小便淋痛等;现代中药药理研究显示抗肿瘤,其抗肿瘤作用类似香菇多糖,是通过免疫机制实现的;此外尚有有保肝利胆作用,抗病原微生物(王本祥《新编中药学辞典》1252页,蒲公英)。
桃仁:味苦、甘,性平;活血化瘀,润肠通便;现代中药药理研究显示有一定程度抗肿瘤作用,能加速血液循环,抗凝、抑制血栓形成,改善血流阻滞、血行障碍等,能使各脏器各组织机能恢复(王本祥《现代中药药理研究》903页,桃仁)。
木瓜:味酸,性温;平肝和胃,舒筋和络,健脾化湿;主治湿痹,吐泻转筋,脚气,水肿,痢疾等;现代中药药理研究显示木瓜有保肝,抗菌,抗肿瘤及抗休克等作用(王本祥《现代中药药理研究》435页,木瓜)。
人参:味甘、味苦,性温;大补元气,生津止渴,安神益智;主治劳伤虚损,食少倦怠,反胃吐食,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿惊悸,久虚不复等一切气血津液不足之证;现代药理研究显示,具有抗肿瘤,提高免疫力,抗氧化,抗应激,抗辐射,抗衰老,促进学习和记忆力,强心,扩张心血管,抗心肌缺血,抗缺氧、保护心肌,降低血粘度,保护和刺激骨髓造血功能,人参皂甙促进刺激垂体-肾上腺皮质功能,促进蛋白质合成,明显降低血糖,抗溃疡,促性激素样作用(雌性为主),(王本祥《现代中药药理研究》1147页,人参)。
桑椹:味甘酸,性寒;补肝益肾,养血生津;主治头晕、目眩、耳鸣、心悸、头发早白、津亏口渴、肠燥便秘;现代中药药理研究显示有促进淋巴细胞转化,促进T淋巴细胞成熟,促进体液免疫功能,促进造血细胞生长,升高外周白细胞,故能促杀癌细胞、降低化疗药物毒副作用等功用(王本祥《现代中药药理研究》1364页,桑椹子)。
枸杞子:味甘,性平;滋补肝肾,滋阴补血,明目,润肺;主治肝肾阴虚,精血虚损诸症,用以防治癌症取自其扶正固本、提高抗病力之能;现代中药药理研究显示增强免疫力,临床应用于联合化疗治疗肝癌能提高生存率和生活质量,增强患者免疫功能,减轻化疗副作用,另有保肝、促进肝细胞再生、防治脂肪肝,降脂,降糖提高糖耐量,抗应激损伤、降压及滋补强壮作用,是中老年肝肾保健固本之要药(王本祥《现代中药药理研究》1343页,枸杞子)。
蛹虫草:味甘,性温;保肺,益肾,止血,化痰;主治虚劳咳嗽、咳血,肾虚阳痿等,本方用以扶正固本又兼以除痰而清癌症邪气之源;现代中药药理研究显示抗肿瘤,抑制癌转移,提高免疫力,抗衰老,抗应激,镇静催眠(王本祥《现代中药药理研究》1250页,冬虫夏草)。
平卧菊三七:味淡,性温,散瘀止血,解毒消肿,其鲜叶和嫩茎嫩茎叶营养丰富,是中老年人补钙的绿色食品;其叶也可生吃,或取鲜叶开水冲泡当茶饮,现代中药药理研究显示抗肿瘤、抗炎、镇痛、止血,镇静等作用(王本祥《现代中药药理研究》824页,菊三七)。
百合:味甘、微苦,性微寒;养阴润肺止咳、清心安神、补中益气;主治肺热阴伤,或阴虚肺燥咳嗽、肺痨、吐血、咯血及虚烦惊悸、失眠多梦;现代药理研究显示百合升高白细胞有防治化疗药环磷酰胺所致的白细胞减少症的作用,抗疲劳强壮身体,耐缺氧,催眠,止咳、祛痰、平喘,保护胃黏膜,抑制迟发过敏反应(王本祥《现代中药药理研究》1360页,百合);所含秋水仙碱有明确的抗癌作用,能抑制癌细胞的增殖。
茶树花:内含成分具有解毒、抑菌、降糖、延缓衰老、防癌抗癌和增强免疫力等功效,其蛋白质、茶多糖、茶多酚、活性抗氧化物质超出茶叶中同类物质含量;茶树花是一种优质蛋白营养源,可与世界公认的抗氧化植物迷迭香媲美;因为茶树花生长期较长,所以含有多种对人体有益的物质,特别是抗氧化物质含量很高,其抗氧化能力也是比较强的;同时还具有滋补、壮体、养颜美容等功效。
余甘子:抗肿瘤、抗诱变、抗致畸、抗肝损伤、降脂减肥、抗动脉硬化、抗病原微生物等作用(郑见仙《功能性食品学》第二版,95页)。
大枣:甘,温;功能补中益气,养血安神;用于脾虚食少,乏力便溏,妇人脏躁(《中华人民共和国药典》一部,21页,大枣);现代药理研究显示大枣具有抗癌,对实验鼠胃腺癌具有抑制作用,抗突变,抗氧化,抗变态反应,镇咳、祛痰,(王本祥《现代中药药理研究》1207页,大枣)。
按上述配方及制备方法制得的抗癌固本适宜于癌症和癌前病变及其高危人群的中药配方,可以生产该类人群长期使用的冲剂、丸剂、片剂、膏剂、胶囊剂、口服液、压片糖果等多种类型的中药剂型和特殊膳食药膳制品;其具有针对癌症病机,以扶正固本、化痰祛瘀、解毒散结相结合、防治并举的系列作用。
具体实施方式:下面结合实施例详述本发明。
实施例1
一种抗癌固本适宜癌症防治的药膳粉
制备方法
将上述原料中的薏苡仁挑拣去杂、剔除霉变,按重量份数称取,以50%的乙醇提取,将提取液经喷雾干燥制得干燥药粉;将刀豆、茯苓、蝮蛇、乌梢蛇、昆布、蒲公英、桃仁、木瓜、人参、桑椹、枸杞子、蛹虫草、平卧菊三七、百合、茶树花、余甘子、大枣挑拣去杂、剔除霉变,按重量份数称取,加入70~80℃的热水内浸泡六小时,煎煮三次,每次煎煮二小时,将三次煎煮液混合,经喷雾干燥制得干燥药粉,与如上薏苡仁提取药粉合并混匀,即成为一种抗癌固本适宜癌症防治的药膳粉,既可以直接冲饮,也可以制作成颗粒剂、浓缩口服液、丸剂、片剂、膏剂、胶囊剂。
实施例2(最佳实施例)
一种抗癌固本适宜癌症防治的药膳粉
制备方法
将上述原料中的薏苡仁挑拣去杂、剔除霉变,按重量份数称取,以50%的乙醇提取,将提取液经喷雾干燥制得干燥药粉;将刀豆、茯苓、蝮蛇、乌梢蛇、昆布、蒲公英、桃仁、木瓜、人参、桑椹、枸杞子、蛹虫草、平卧菊三七、百合、茶树花、余甘子、大枣挑拣去杂、剔除霉变,按重量份数称取,加入70~80℃的热水内浸泡六小时,煎煮三次,每次煎煮二小时,将三次煎煮液混合,经喷雾干燥制得干燥药粉,与如上薏苡仁提取药粉合并混匀,即成为一种抗癌固本适宜癌症防治的药膳粉,既可以直接冲饮,也可以制作成颗粒剂、浓缩口服液、丸剂、片剂、膏剂、胶囊剂。
实施例3
一种抗癌固本适宜癌症防治的药膳粉
制备方法
将上述原料中的薏苡仁挑拣去杂、剔除霉变,按重量份数称取,以50%的乙醇提取,将提取液经喷雾干燥制得干燥药粉;将刀豆、茯苓、蝮蛇、乌梢蛇、昆布、蒲公英、桃仁、木瓜、人参、桑椹、枸杞子、蛹虫草、平卧菊三七、百合、茶树花、余甘子、大枣挑拣去杂、剔除霉变,按重量份数称取,加入70~80℃的热水内浸泡六小时,煎煮三次,每次煎煮二小时,将三次煎煮液混合,经喷雾干燥制得干燥药粉,与如上薏苡仁提取药粉合并混匀,即成为一种抗癌固本适宜癌症防治的药膳粉,既可以直接冲饮,也可以制作成颗粒剂、浓缩口服液、丸剂、片剂、膏剂、胶囊剂。
Claims (2)
1.一种抗癌固本适宜癌症防治的药膳粉,其特征在于:它由下述重量份数原料制成的中药粉:
将上述原料中的薏苡仁挑拣去杂、剔除霉变,按重量份数称取,以50%的乙醇提取,将提取液经喷雾干燥制得干燥药粉;将刀豆、茯苓、蝮蛇、乌梢蛇、昆布、蒲公英、桃仁、木瓜、人参、桑椹、枸杞子、蛹虫草、平卧菊三七、百合、茶树花、余甘子、大枣挑拣去杂、剔除霉变,按重量份数称取,加入70~80℃的热水内浸泡六小时,煎煮三次,每次煎煮二小时,将三次煎煮液混合,经喷雾干燥制得干燥药粉,与如上薏苡仁提取药粉合并混匀,即成为生产制做一种抗癌固本适宜癌症防治的药膳粉,既可以直接冲饮,也可以制作成颗粒剂、浓缩口服液、丸剂、片剂、膏剂、胶囊剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011643413.3A CN112569315A (zh) | 2020-12-31 | 2020-12-31 | 一种抗癌固本适宜癌症防治的药膳粉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011643413.3A CN112569315A (zh) | 2020-12-31 | 2020-12-31 | 一种抗癌固本适宜癌症防治的药膳粉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112569315A true CN112569315A (zh) | 2021-03-30 |
Family
ID=75145609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011643413.3A Pending CN112569315A (zh) | 2020-12-31 | 2020-12-31 | 一种抗癌固本适宜癌症防治的药膳粉 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112569315A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1935245A (zh) * | 2006-09-14 | 2007-03-28 | 唐先平 | 一种具有防癌、抗癌作用的营养粉 |
-
2020
- 2020-12-31 CN CN202011643413.3A patent/CN112569315A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1935245A (zh) * | 2006-09-14 | 2007-03-28 | 唐先平 | 一种具有防癌、抗癌作用的营养粉 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105265672B (zh) | 一种核桃分心木茶的生产方法 | |
CN104799048A (zh) | 一种增强黄沙鳖抗病能力的饲料及其制备方法 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN112618691A (zh) | 一种具有补气血功效的中药组合物及其制备方法和应用 | |
CN103653009A (zh) | 一种美容养颜药膳乌鸡 | |
CN102552779A (zh) | 具有净化人体血液作用的保健中药组合物及其保健制品 | |
CN111249410A (zh) | 一种保肝解毒排脂防治肝损伤恢复肝功能的药膳饮料 | |
CN110694013A (zh) | 一种缓解脱发的压片糖果及其制备工艺 | |
CN108939043A (zh) | 一种鲨鱼软骨糖蛋白及其抗癌用途 | |
CN112569315A (zh) | 一种抗癌固本适宜癌症防治的药膳粉 | |
CN104825817B (zh) | 一种具有抗肿瘤作用的中药制剂 | |
KR102436045B1 (ko) | 생약재 미네랄 효모 발효액을 이용하여 제조되는 발효 흑삼 조성물 및 그 제조방법 | |
CN108355052B (zh) | 一种治疗放化疗后白细胞降低的药物及其制备方法与应用 | |
CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
CN102357151A (zh) | 一种延缓衰老的中药组合物及其制备工艺 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN105031550A (zh) | 一种含蝎毒大分子的治疗肿瘤新型中药配方 | |
CN106701595B (zh) | 一种野生肉灵芝快速驯养的方法 | |
CN110882362A (zh) | 一种调理糖尿病的中药食疗制品及其制备方法 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
CN104840874A (zh) | 一种用于动脉瘤术后康复治疗的中药丸剂及制备方法 | |
CN112569316A (zh) | 一种抗癌中药的配方及制备方法 | |
CN110604769A (zh) | 一种多功能复合植物多糖 | |
CN107048259A (zh) | 用十三种珍贵食材配制的健康食品及其配制方法 | |
CN108452047B (zh) | 延缓衰老抑制肿瘤细胞生长改善心脑血管微循环的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210330 |